Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Ethical considerations in rapid and novel treatments in psychiatry
    Published on 2023-06-30
    2 years ago
  • From childhood adversity to latent stress vulnerability in adulthood: the mediating roles of sleep disturbances and HPA axis dysfunction
    Published on 2023-06-30
    2 years ago
  • Does acute stress play a role in the lasting therapeutic effects of psychedelic drugs?
    Published on 2023-06-30
    2 years ago
  • Correction: Testosterone eliminates strategic prosocial behavior through impacting choice consistency in healthy males
    Published on 2023-06-29
    2 years ago
  • Venlafaxine’s effect on resilience to stress is associated with a shift in the balance between glucose and fatty acid utilization
    Published on 2023-06-28
    2 years ago
  • Neurosteroids: mechanistic considerations and clinical prospects
    Published on 2023-06-27
    2 years ago
  • Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
    Published on 2023-06-27
    2 years ago
« Previous 1 … 94 95 96 97 98 … 143 Next »
Journal of Psychopharmacology
  • Selective activation of D1 dopamine receptors exerts antidepressant-like activity in rats
    Published on 2020-10-09
    5 years ago
  • Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Published on 2020-09-10
    5 years ago
  • Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale
    Published on 2020-09-09
    5 years ago
  • Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
    Published on 2020-09-09
    5 years ago
  • Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
    Published on 2020-09-09
    5 years ago
  • The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
    Published on 2020-08-28
    5 years ago
  • The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction
    Published on 2020-08-28
    5 years ago
« Previous 1 … 94 95 96 97 98 … 134 Next »
European Neuropsychopharmacology
  • Are we ready for precision medicine for Autism? And who wants it?
    Published on 2021-04-12
    5 years ago
  • Drug development in ASD, an ISCTM-ECNP joint adventure
    Published on 2021-04-06
    5 years ago
  • GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site
    Published on 2021-04-03
    5 years ago
  • Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis
    Published on 2021-04-03
    5 years ago
  • Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS)
    Published on 2021-04-03
    5 years ago
  • Comorbidities and behavioral issues
    Published on 2021-04-02
    5 years ago
  • Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk
    Published on 2021-04-02
    5 years ago
« Previous 1 … 94 95 96 97 98 … 155 Next »

   Pharma Pub